Patents by Inventor Steven Collier

Steven Collier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12052981
    Abstract: A person may wish to use a submersible light to attract aquatic life, including fish. The submersible light described herein may include a mounting body around which outward facing lights are disposed. The lights may be powered with a connected power cord. To prevent water from contacting sensitive electronics within the submersible light, a water tight enclosure is created between the outside of the mounting body and an outer transparent covering. The submersible light may have ballast material inside the mounting body. The ballast material affects the buoyancy of the mounting body when it is placed in the water. The submersible lighting device may also emit a variety of light spectrums and light intensity levels which the user can control.
    Type: Grant
    Filed: April 8, 2023
    Date of Patent: August 6, 2024
    Inventors: John Collier, Mark Steven Collier
  • Publication number: 20180312530
    Abstract: Novel processes, and intermediates, for making alkylated arylpiperazine and alkylated arylpiperidine compounds of the general formulas (I) and (VII), respectively wherein, R1 and R2 are individually selected from hydrogen, alkyl, substituted or alkyl; n=0, 1, or 2; Y=NR3R4, OR5, or SR5, where R3 and R4 are individually selected from acyl or sulfonyl, and where R5 is aryl or heteroaryl, or heterocyclic; and Ar is an aryl, heteroaryl, or heterocyclic compound.
    Type: Application
    Filed: April 20, 2018
    Publication date: November 1, 2018
    Inventors: Daniel J. COUGHLIN, Jeremy C. WILT, Da-Ming GOU, Steven COLLIER
  • Publication number: 20180244618
    Abstract: Provided is a method for preparing a structure directing agent (SDA) for crystalline molecular sieve synthesis comprising the steps of (a) hydrolyzing analkyl sulfate counterion of a quaternary ammonium salt to produce an organic ammonium salt having a hydrogen sulfate counterion; and (b) contacting the organic ammonium salt having the hydrogen sulfate counterion with a source of hydroxide in solution to form an organic ammonium salt having a hydroxide counterion; wherein the organic ammonium salt is a structure directing agent (SDA) for crystalline molecular sieve synthesis.
    Type: Application
    Filed: May 1, 2018
    Publication date: August 30, 2018
    Inventors: Steven COLLIER, Da-Ming GOU, Jeremy WILT
  • Patent number: 9957283
    Abstract: Novel processes, and intermediates, for making alkylated arylpiperazine and alkylated arylpiperidine compounds of the general formulas (I) and (VII), respectively wherein, R1 and R2 are individually selected from hydrogen, alkyl, substituted or alkyl; n=0, 1, or 2; Y=NR3R4, OR5, or SR5, where R3 and R4 are individually selected from acyl or sulfonyl, and where R5 is aryl or heteroaryl, or heterocyclic; and Ar is an aryl, heteroaryl, or heterocyclic compound.
    Type: Grant
    Filed: October 16, 2017
    Date of Patent: May 1, 2018
    Assignee: Johnson Matthey Public Limited Company
    Inventors: Daniel J. Coughlin, Jeremy C. Wilt, Da-Ming Gou, Steven Collier
  • Publication number: 20180099982
    Abstract: Novel processes, and intermediates, for making alkylated arylpiperazine and alkylated arylpiperidine compounds of the general formulas (I) and (VII), respectively wherein, R1 and R2 are individually selected from hydrogen, alkyl, substituted or alkyl; n=0, 1, or 2; Y=NR3R4, OR5, or SR5, where R3 and R4 are individually selected from acyl or sulfonyl, and where R5 is aryl or heteroaryl, or heterocyclic; and Ar is an aryl, heteroaryl, or heterocyclic compound.
    Type: Application
    Filed: October 16, 2017
    Publication date: April 12, 2018
    Inventors: Daniel J. COUGHLIN, Jeremy C. WILT, Da-Ming GOU, Steven COLLIER
  • Publication number: 20180016231
    Abstract: Provided is a method for preparing a structure directing agent (SDA) for crystalline molecular sieve synthesis comprising the steps of (a) hydrolyzing analkyl sulfate counterion of a quaternary ammonium salt to produce an organic ammonium salt having a hydrogen sulfate counterion; and (b) contacting the organic ammonium salt having the hydrogen sulfate counterion with a source of hydroxide in solution to form an organic ammonium salt having a hydroxide counterion; wherein the organic ammonium salt is a structure directing agent (SDA) for crystalline molecular sieve synthesis.
    Type: Application
    Filed: April 20, 2016
    Publication date: January 18, 2018
    Inventors: Steven COLLIER, Da-Ming GOU, Jeremy WILT
  • Patent number: 9790237
    Abstract: Novel processes, and intermediates, for making alkylated arylpiperazine and alkylated arylpiperidine compounds of the general formulas (I) and (VII), respectively wherein, R1 and R2 are individually selected from hydrogen, alkyl, substituted or alkyl; n=0, 1, or 2; Y=NR3R4, OR5, or SR5, where R3 and R4 are individually selected from acyl or sulfonyl, and where R5 is aryl or heteroaryl, or heterocyclic; and Ar is an aryl, heteroaryl, or heterocyclic compound.
    Type: Grant
    Filed: June 12, 2015
    Date of Patent: October 17, 2017
    Assignee: Johnson Matthey Public Limited Company
    Inventors: Daniel J. Coughlin, Jeremy C. Wilt, Da-Ming Gou, Steven Collier
  • Publication number: 20160304457
    Abstract: Provided is a method for preparing a structure directing agent (SDA) for crystalline molecular sieve synthesis comprising the steps of (a) hydrolyzing analkyl sulfate counterion of a quaternary ammonium salt to produce an organic ammonium salt having a hydrogen sulfate counterion; and (b) contacting the organic ammonium salt having the hydrogen sulfate counterion with a source of hydroxide in solution to form an organic ammonium salt having a hydroxide counterion; wherein the organic ammonium salt is a structure directing agent (SDA) for crystalline molecular sieve synthesis.
    Type: Application
    Filed: April 20, 2016
    Publication date: October 20, 2016
    Inventors: Steven COLLIER, Da-Ming GOU, Jeremy WILT
  • Patent number: 9267159
    Abstract: The present invention relates to non-naturally occurring polypeptides useful for preparing armodafinil, polynucleotides encoding the polypeptides, and methods of using the polypeptides. The non-naturally occurring polypeptides of the present invention are effective in carrying out biocatalytic conversion of the (i) 2-(benzhydrylsulfinyl)acetamide to (?)-2-[(R)-(diphenyl-methyl)sulfinyl]acetamide (armodafinil), or (ii) benzhydryl-thioacetic acid to (R)-2-(benzhydrylsulfinyl)acetic acid, which is a pivotal intermediate in the synthesis of armodafinil, in enantiomeric excess.
    Type: Grant
    Filed: December 7, 2011
    Date of Patent: February 23, 2016
    Assignee: CODEXIS, INC.
    Inventors: Ee Lui Ang, Oscar Alvizo, Behnaz Behrouzian, Michael Clay, Steven Collier, Ellen Eberhard, Fan Jaslyn Fu, Shiwei Song, Derek Smith, Magnus Widegren, Robert Wilson, Junye Xu, Jun Zhu
  • Publication number: 20130260426
    Abstract: The present invention relates to non-naturally occurring polypeptides useful for preparing armodafinil, polynucleotides encoding the polypeptides, and methods of using the polypeptides. The non-naturally occurring polypeptides of the present invention are effective in carrying out biocatalytic conversion of the (i) 2-(benzhydrylsulfinyl)acetamide to (?)-2-[(R)-(diphenyl-methyl)sulfinyl]acetamide (armodafinil), or (ii) benzhydryl-thioacetic acid to (R)-2-(benzhydrylsulfinyl)acetic acid, which is a pivotal intermediate in the synthesis of armodafinil, in enantiomeric excess.
    Type: Application
    Filed: December 7, 2011
    Publication date: October 3, 2013
    Inventors: Ee Lui Ang, Oscar Alvizo, Behnaz Behrouzian, Michael Clay, Steven Collier, Ellen Eberhard, Fan Jaslyn Fu, Shiwei Song, Derek Smith, Magnus Widegren, Robert Wilson, Junye Xu, Jun Zhu
  • Patent number: 7604876
    Abstract: An impact resistant clad composite armor which includes a ceramic core, and a layer of bulk amorphous alloy surrounding the ceramic core and preferably bonded chemically to the ceramic core and a method of manufacturing such armor is provided.
    Type: Grant
    Filed: December 18, 2006
    Date of Patent: October 20, 2009
    Assignee: Liquidmetal Technologies, Inc.
    Inventors: Steven Collier, Atakan Peker
  • Publication number: 20090239088
    Abstract: An impact resistant clad composite armor which includes a ceramic core, and a layer of bulk amorphous alloy surrounding the ceramic core and preferably bonded chemically to the ceramic core and a method of manufacturing such armor is provided.
    Type: Application
    Filed: December 18, 2006
    Publication date: September 24, 2009
    Inventors: Steven Collier, Atakan Peker
  • Publication number: 20070125193
    Abstract: Disclosed herein is an apparatus that relates to a gear set. The apparatus includes, a housing, a first gear movable in the housing such that a first axis defined by the first gear is repositionable relative to the housing, a second gear in mesh with the first gear, and a second axis defined by the second gear. The apparatus constrains movement of the first axis to a plane containing both the first axis and a line commonly perpendicular to the first axis and the second axis, and a biasing member that urges the first gear toward the second gear.
    Type: Application
    Filed: November 6, 2006
    Publication date: June 7, 2007
    Applicant: DELPHI TECHNOLOGIES, INC.
    Inventors: Michael Augustine, Christian Ross, Steven Collier-Hallman, Mohammad Islam
  • Publication number: 20070093665
    Abstract: The present invention relates to a process for preparation of a delta-9-tetrahydrocannabinol compound or derivative thereof involving treating a first intermediate compound with an organoaluminum-based Lewis acid catalyst, under conditions effective to produce the delta-9-tetrahydrocannabinol compound or derivative thereof. Another aspect of the present invention relates to a process for preparation of a cannabidiol or cannabidiolate compound involving reacting a first starting compound with a second starting compound in the presence of a metal triflate catalyst, under conditions effective to form the cannabidiol or cannabidiolate compound. The present invention also relates to a compound of the formula: where R8, R9, and R10 are the same or different and independently selected from the group consisting of H, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or halo, with R1, R2, and R3 defined herein.
    Type: Application
    Filed: September 28, 2006
    Publication date: April 26, 2007
    Applicant: AMR Technology, Inc.
    Inventors: David Burdick, Steven Collier, Frederic Jos, Betina Biolatto, Bernhard Paul, Harold Meckler, Mark Helle, Alicia Habershaw
  • Patent number: 7157158
    Abstract: An impact resistant clad composite armor which includes a ceramic core, and a layer of bulk amorphous alloy surrounding the ceramic core and preferably bonded chemically to the ceramic core and a method of manufacturing such armor is provided.
    Type: Grant
    Filed: March 11, 2003
    Date of Patent: January 2, 2007
    Assignee: LiquidMetal Technologies
    Inventors: Steven Collier, Atakan Peker
  • Publication number: 20060269765
    Abstract: An impact resistant clad composite armor which includes a ceramic core, and a layer of bulk amorphous alloy surrounding the ceramic core and preferably bonded chemically to the ceramic core and a method of manufacturing such armor is provided.
    Type: Application
    Filed: March 11, 2003
    Publication date: November 30, 2006
    Inventors: Steven Collier, Atakan Peker
  • Publication number: 20060135409
    Abstract: A process for and intermediates in the preparation of canfosfamide and its salts. Some of the intermediates have anticancer activity.
    Type: Application
    Filed: December 21, 2004
    Publication date: June 22, 2006
    Inventors: William Boulanger, Steven Collier, Stephen Eastham, Dennis Edie, Ronan Guevel, Pedro Abad, R. Herr, Hans Kjaersgaard, Harold Meckler, Robert Polomski, Steven Schow, Pavel Zhichkin
  • Publication number: 20060024364
    Abstract: The present invention relates to a dry blend, used for forming azithromycin tablets by direct compression, comprising non-dihydrate azithromycin and at least one pharmaceutically acceptable excipient. This invention also relates to an azithromycin tablet comprising non-dihydrate azithromycin and at least one pharmaceutically acceptable excipient. Preferably, the azithromycin tablet is formed by directly compressing the dry blend, of the present invention, to form said azithromycin tablet. Preferably, the azithromycin tablet, of the present invention, contains a dosage of 250 mgA, 500 mgA or 600 mgA of azithromycin. This invention further relates to an azithromycin tablet which is produced by forming a dry blend of a non-granulated azithromycin form A and at least one pharmaceutically acceptable excipient. The azithromycin tablet is then formed by directly compressing the dry blend.
    Type: Application
    Filed: August 26, 2005
    Publication date: February 2, 2006
    Inventors: Brendan Murphy, Steven Collier, Ernest Quan, Barbara Johnson
  • Publication number: 20060024363
    Abstract: The present invention relates to a dry blend, used for forming azithromycin tablets by direct compression, comprising non-dihydrate azithromycin and at least one pharmaceutically acceptable excipient. This invention also relates to an azithromycin tablet comprising non-dihydrate azithromycin and at least one pharmaceutically acceptable excipient. Preferably, the azithromycin tablet is formed by directly compressing the dry blend, of the present invention, to form said azithromycin tablet. Preferably, the azithromycin tablet, of the present invention, contains a dosage of 250 mgA, 500 mgA or 600 mgA of azithromycin. This invention further relates to an azithromycin tablet which is produced by forming a dry blend of a non-granulated azithromycin form A and at least one pharmaceutically acceptable excipient. The azithromycin tablet is then formed by directly compressing the dry blend.
    Type: Application
    Filed: August 26, 2005
    Publication date: February 2, 2006
    Inventors: Brendan Murphy, Steven Collier, Ernest Quan, Barbara Johnson
  • Patent number: RE45830
    Abstract: An impact resistant clad composite armor which includes a ceramic core, and a layer of bulk amorphous alloy surrounding the ceramic core and preferably bonded chemically to the ceramic core and a method of manufacturing such armor is provided.
    Type: Grant
    Filed: May 1, 2014
    Date of Patent: December 29, 2015
    Assignee: Crucible Intellectual Property, LLC
    Inventors: Steven Collier, Atakan Peker